Randomized, placebo-controlled, double-blind study of the efficacy of lanreotide 30 mg PR in the treatment of pancreatic and enterocutaneous fistulae.

Source:http://linkedlifedata.com/resource/pubmed/id/19953707

Download in:

View as

General Info

PMID
19953707